Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 211

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder

Open access
Rethorst, C D, Toups, M S, Greer, T L, Nakonezny, P A, Carmody, T J, Grannemann, B D, Huebinger, R M, Barber, R C, Trivedi, M H·2013·Molecular Psychiatry

Abstract

Exercise is an efficacious treatment for major depressive disorder (MDD) and has independently been shown to have anti-inflammatory effects in non-depressed subjects. Patients with MDD have elevated inflammatory cytokines but it is not known if exercise affects inflammation in MDD patients and whether these changes are clinically relevant. In the TReatment with Exercise Augmentation for Depression (TREAD) study, participants who were partial responders to a selective serotonin reuptake inhibitor were randomized to receive one of two doses of exercise: 16 kilocalories per kilogram of body weight per week (KKW), or 4 KKW for 12 weeks. Blood samples were collected before initiation and again at the end of the 12-week exercise intervention. Serum was analyzed using a multiplexed ELISA for interferon-γ (IFN-γ), interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α). Higher baseline levels of TNF-α were associated with greater decrease in depression symptoms over the 12-week exercise period (P<0.0001). In addition, a significant positive correlation between change in IL-1β and change in depression symptom scores was observed (P=0.04). There were no significant changes in mean level of any cytokine following the 12-week intervention, and no significant relationship between exercise dose and change in mean cytokine level. Results suggest that high TNF-α may differentially predict better outcomes with exercise treatment as opposed to antidepressant medications for which high TNF-α is linked to poor response. Our results also confirm findings from studies of antidepressant medications that tie decreasing IL-1β to positive depression treatment outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mp.2012.125

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 23

  1. Mather AS, Rodriguez C, Guthrie MF, McHarg AM, Reid IC, McMurdo ME . Effects of exercise on depressive symptoms in older adults with poorly responsive depressive disorder: randomised controlled trial. Br J Psychiatry 2002; 180: 411. · DOI · Paper page
  2. Trivedi MH, Greer TL, Church TS, Carmody TJ, Grannemann BD, Galper DI et al. Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose comparison. J Clin Psychiatry 2011; 72: 677. · DOI · Paper page
  3. Rethorst CD, Landers DM, Nagoshi CT, Ross JT . Efficacy of exercise in reducing depressive symptoms across 5-HTTLPR genotypes. Med Sci Sports Exerc 2010; 42: 2141–2147. · DOI
  4. Leo R, Di Lorenzo G, Tesauro M, Razzini C, Forleo GB, Chiricolo G et al. Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy. J Clin Psychiatry 2006; 67: 1760–1766. · DOI
  5. Kagaya A, Kugaya A, Takebayashi M, Fukue-Saeki M, Saeki T, Yamawaki S et al. Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan. Neuropsychobiology 2001; 43: 59. · DOI
  6. Basterzi AD, Aydemir C, Kisa C, Aksaray S, Tuzer V, Yazici K et al. IL-6 levels decrease with SSRI treatment in patients with major depression. Hum Psychopharmacol 2005; 20: 473–476. · DOI · Paper page
  7. Yoshimura R, Hori H, Ikenouchi-Sugita A, Umene-Nakano W, Ueda N, Nakamura J . Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 722–726. · DOI · Paper page
  8. Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E . Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 2003; 170: 429–433. · DOI · Paper page
  9. Goldhammer E, Tanchilevitch A, Maor I, Beniamini Y, Rosenschein U, Sagiv M . Exercise training modulates cytokines activity in coronary heart disease patients. Int J Cardiol 2005; 100: 93. · DOI · Paper page
  10. Smith J, Dykes R, Douglas J, Krishnaswamy G, Berk S . Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA 1999; 281: 1722. · DOI · Paper page
  11. Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO . Exercise treatment for depression: efficacy and dose response. Am J Prev Med 2005; 28: 1–8. · DOI · Paper page
  12. Trivedi MH, Greer TL, Grannemann BD, Church TS, Galper DI, Sunderajan P et al. TREAD: TReatment with Exercise Augmentation for Depression: study rationale and design. Clin Trials 2006; 3: 291. · DOI
  13. Hamilton M . A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56. · DOI · Paper page
  14. Lazzeroni LC, Ray A . The cost of large numbers of hypothesis tests on power, effect size and sample size. Mol Psychiatry 2012; 17: 108–114. · DOI
  15. Bender R, Lange S . Adjusting for multiple testing–when and how? J Clin Epidemiol 2001; 54: 343–349. · DOI · Paper page
  16. Hannestad J, DellaGioia N, Bloch M . The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 2011; 36: 2452–2459. · DOI · Paper page
  17. Song C, Halbreich U, Han C, Leonard B, Luo H . Imbalance between pro-and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment. Pharmacopsychiatry 2009; 42: 182. · DOI · Paper page
  18. Helmich I, Latini A, Sigwalt A, Carta MG, Machado S, Velasques B et al. Neurobiological alterations induced by exercise and their impact on depressive disorders [corrected]. Clin Pract Epidemiol Ment Health 2010; 6: 115–125. · DOI
  19. Ridker P, Wilson P, Grundy S . Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004; 109: 2818. · DOI · Paper page
  20. Nicklas BJ, Beavers KM . Exercise, weight loss, and effects on inflammation. Current Cardiovascular Risk Reports 2010; 4: 284–292. · DOI
  21. Ivy JL . Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus. Sport Med 1997; 24: 321–336. · DOI · Paper page
  22. Arsenault BJ, CÙtÈ M, Cartier A, Lemieux I, DesprÈs JP, Ross R et al. Effect of exercise training on cardiometabolic risk markers among sedentary, but metabolically healthy overweight or obese postmenopausal women with elevated blood pressure. Atherosclerosis 2009; 207: 530. · DOI
  23. Church TS, Martin CK, Thompson AM, Earnest CP, Mikus CR, Blair SN . Changes in weight, waist circumference and compensatory responses with different doses of exercise among sedentary, overweight postmenopausal women. PLoS One 2009; 4: e4515. · DOI · Paper page

Cited by

See all 211

Metadata

Authors
Rethorst, C. D., Toups, M. S., Greer, T. L., Nakonezny, P. A., Carmody, T. J., Grannemann, B. D., Huebinger, R. M., Barber, R. C., & Trivedi, M. H.
Venue
Molecular Psychiatry
Published
2012-08-28
Volume
18
Issue
10
Pages
1119-1124
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W2116159412
Cited by
211
References
27
FWCI
3.27
Type
journal article
Language
en
Open access
green
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.